Dietary flavonoid derivatives enhance chemotherapeutic effect by inhibiting the DNA damage response pathway

Area of Science:

• Biochemistry
• Oncology
• Molecular Biology

Background:

• Flavonoids, abundant polyphenolic compounds in fruits and vegetables, are linked to reduced mortality in breast cancer patients.
• Existing research suggests flavonoids may improve chemotherapy efficacy, but specific mechanisms remain under investigation.
• Dietary intake of flavonoids is a key area of interest in cancer research.

Purpose of the Study:

• To investigate a novel mechanism by which dietary flavonoids impact DNA damage checkpoints and repair pathways in cancer cells.
• To explore the role of flavonoids in modulating the response to DNA-damaging chemotherapy agents.
• To determine if flavonoids can enhance the sensitivity of cancer cells to chemotherapy.

Main Methods:

• Breast cancer cells were treated with ultraviolet irradiation, cisplatin, or etoposide.
• The effect of dietary flavonoids on Chk1 phosphorylation was assessed.
• Clonogenic cell growth was measured following flavonoid and chemotherapy treatment.

Main Results:

• Dietary flavonoids were found to inhibit Chk1 phosphorylation in breast cancer cells.
• Flavonoids decreased clonogenic cell growth when cells were exposed to DNA-damaging agents.
• The ATR-Chk1 pathway, crucial for DNA replication stress response, was implicated.

Conclusions:

• Dietary flavonoids can inhibit DNA damage checkpoints and repair pathways, specifically targeting the ATR-Chk1 signaling.
• Flavonoid derivatives may reduce chemotherapy side effects by increasing the sensitivity of cycling cancer cells.
• Increased intake of dietary flavonoids could be beneficial for breast cancer patients undergoing DNA-damaging chemotherapy.